Company no longer exists

greenovation Biotech GmbH ✟

Inselwiesenstr. 10
74076 Heilbronn
Germany
Profile Products News
To the successor

About Greenovation Biotech

Production of pharmaceutically relevant proteins in a moss bioreactor

Read more about Greenovation Biotech

Greenovation Biotech no longer exists.
The successor of this company is:

eleva GmbH

eleva

Freiburg im Breisgau, DE

View company

News about Greenovation Biotech

Greenovation Biotech

16-Oct-2007 | business & finance

Joint process development between Sartorius Stedim Biotech and greenovation Biotech GmbH

Sartorius Stedim Biotech GmbH and greenovation Biotech GmbH agreed to collaborate on the project of processscale implementation of the innovative, plant- ...

Read news
Greenovation Biotech

20-Jul-2007 | politics & laws

greenovation Biotech gets a European Patent for the Reconstruction of Human Sugar Structures in Moss

greenovation Biotech GmbH has received a European patent, offering full protection for the production of improved glycoproteins in moss. By making directed ...

Read news
Greenovation Biotech

26-Jun-2006 | business & finance

Bayer Innovation announces licensing agreement with greenovation Biotech

Bayer Innovation GmbH and greenovation Biotech GmbH have concluded a licensing and service agreement in the field of protein glycosylation in plants. This ...

Read news
Greenovation Biotech

25-Jul-2005 | research and development

greenovation and AM-Pharma announce successful production of alkaline phosphatase in moss

greenovation Biotech GmbH and AM-Pharma B.V. announced today that they have completed a major milestone in the development of a new production system for ...

Read news
Greenovation Biotech

27-Nov-2003 | science

Dow and greenovation will collaborate on glycosylation research for transgenic plant systems

San Diego/Freiburg - The Dow Chemical Company and greenovation Biotech will collaborate in research to develop fully mammalian-like plant glycosylation ...

Read news
Greenovation Biotech

01-Aug-2003 | science

First announcement of the successful production of a therapeutic antibody in moss (Physcomitrella patens)

London/Freiburg - Dr Sabrina Wagner (CEO, greenovation Biotech) and Dr Tarran Jones (CEO, AERES Biomedical) announced today that greenovation (Freiburg, ...

Read news
Show more news about Greenovation Biotech

Product portfolio of Greenovation Biotech

Product portfolio

Show all

Last viewed contents

Forecasting cancer recurrence

Go to page
Encap Drug Delivery - Livingston, United Kingdom

Encap Drug Delivery - Livingston, United Kingdom

Go to page
Eyesight & Vision GmbH - Nürnberg, Germany

Eyesight & Vision GmbH - Nürnberg, Germany

Go to page

‘On the origin of nematodes’ – A phylogenetic tree of the world’s most numerous group of animals - Wageningen UR publishes phylogenetic tree of nematodes

Go to page

Transition Therapeutics Strengthens Drug Discovery Group

Go to page